Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · IEX Real-Time Price · USD
6.71
+0.43 (6.85%)
Mar 28, 2024, 4:00 PM EDT - Market closed
Foghorn Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for FHTX stock have an average target of 14.5, with a low estimate of 6.00 and a high estimate of 20. The average target predicts an increase of 116.10% from the current stock price of 6.71.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for FHTX stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wedbush | Wedbush | Buy Reiterates $13 | Buy | Reiterates | $13 | +93.74% | Mar 8, 2024 |
Morgan Stanley | Morgan Stanley | Hold Maintains $10 → $6 | Hold | Maintains | $10 → $6 | -10.58% | Nov 13, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +198.06% | Aug 7, 2023 |
Morgan Stanley | Morgan Stanley | Hold Maintains $13 → $10 | Hold | Maintains | $13 → $10 | +49.03% | Jul 6, 2023 |
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $21 → $19 | Strong Buy | Maintains | $21 → $19 | +183.16% | Jun 29, 2023 |
Financial Forecast
Revenue This Year
32.36M
from 34.16M
Decreased by -5.25%
Revenue Next Year
37.92M
from 32.36M
Increased by 17.17%
EPS This Year
-2.29
from -2.34
EPS Next Year
-1.89
from -2.29
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 52.5M | 63.0M | 102.8M | 345.3M | 610.9M |
Avg | 32.4M | 37.9M | 64.0M | 170.1M | 312.5M |
Low | n/a | n/a | 39.5M | 76.3M | 162.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 53.7% | 94.7% | 171.1% | 439.6% | 259.2% |
Avg | -5.2% | 17.2% | 68.8% | 165.8% | 83.7% |
Low | - | - | 4.2% | 19.3% | -4.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.84 | -1.51 | -1.17 | 1.96 | 5.34 |
Avg | -2.29 | -1.89 | -1.83 | 0.14 | 2.33 |
Low | -2.74 | -2.48 | -2.43 | -1.56 | -0.51 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 3,642.6% |
Avg | - | - | - | - | 1,532.1% |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.